EMA Recommends Extending Indications for Decitabine / Cedazuridine By Ogkologos - May 29, 2026 53 0 Facebook Twitter Google+ Pinterest WhatsApp New indication concerns a combination with venetoclax for the treatment of adult patients with newly diagnosed AML Source RELATED ARTICLESMORE FROM AUTHOR ESMO Joins WHO Global Clinical Trials Forum to Strengthen Global Oncology Research Ecosystems EMA Recommends Extension of Therapeutic Indications for Enfortumab Vedotin Selinexor plus Ruxolitinib Reduces Spleen Volume, but Does Not Improve Symptom Responses Over Ruxolitinib in Patients with JAK Inhibitor-Naïve Myelofibrosis MOST POPULAR Immunotherapy Effective in Alveolar Soft Part Sarcoma January 9, 2019 How I Balance Being Optimistic and Realistic During Advanced Lung Cancer December 29, 2021 How keeping active during cancer treatment has helped Mary and Keith September 26, 2022 Telehealth-Based Cancer Care Surged during COVID. Will It Continue? March 9, 2022 Load more HOT NEWS EMA Recommends Extending Indications for Zanubrutinib to Include Treatment of Patients... Sun Exposure Lowers Risk of Breast Cancer, Study Finds Cómo mantenerse seguro e independiente durante el tratamiento contra el cáncer Breast Cancer Survivor Comes First Woman In The World To Give...
